|
|
|
||
|
The course introduces the structure of the pharmaceutical industry, the development of medicinal products, clinical development and bioequivalence studies of generics.<br>
The course is held at Zentiva Prague, and takes place in a 3-day block. The course is provided by Zentiva's professional staff.
Last update: Šklubalová Zdeňka, doc. PharmDr., Ph.D. (30.07.2025)
|
|
||
|
The condition for credit is 100% participation in practical training at the Zentiva Last update: Šklubalová Zdeňka, doc. PharmDr., Ph.D. (30.07.2025)
|
|
||
|
Povinná:
Doporučená:
Last update: prepocet_literatura.php (14.08.2025)
|
|
||
|
Teaching is carried out in the form of workshops and excursions to laboratories and production (3 days) Last update: Šklubalová Zdeňka, doc. PharmDr., Ph.D. (30.07.2025)
|
|
||
|
The subject is completed with a credit. Last update: Šklubalová Zdeňka, doc. PharmDr., Ph.D. (30.07.2025)
|
|
||
|
Basic information about the role of the pharmaceutical industry, the importance of generics Structure of a pharmaceutical company, future employment opportunities for students in a pharmaceutical company and personnel support Structure of generic drug development, project management, intellectual property Clinical development and bioequivalence studies Regulatory issues, pharmacovigilance Quality assurance and GMP Last update: Šklubalová Zdeňka, doc. PharmDr., Ph.D. (30.07.2025)
|
|
||
|
Last update: Marek Josef, Ing. (30.01.2018)
|
|
||
|
After completing the course, students will be able to use the following terms (including their commonly used abbreviations): generic drug, generic company, active ingredient (API), pharmaceutical company structure, bioequivalence, quality assurance, GMP, intellectual property, pharmacovigilance. Learning outcomes: Based on the knowledge and skills acquired, the student will: • explain the role of the pharmaceutical industry • describe the structure of a pharmaceutical company • discuss the importance of generics • understand the issues of generic drug development, clinical development and bioequivalence studies • understand regulatory issues, quality assurance, GMP and the principles of intellectual property protection Last update: Šklubalová Zdeňka, doc. PharmDr., Ph.D. (30.07.2025)
|
